Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer

Chin, Suyin P., Marthick, James R., West, Alison C., Short, Annabel K., Chuckowree, Jyoti, Polanowski, Andrea M., Thomson, Russell J., Holloway, Adele F. and Dickinson, Joanne L. (2015). Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer. Prostate,75(7):723-734.

Document type: Journal Article
Citation counts: Altmetric Score Altmetric Score is 1
Google Scholar Search Google Scholar

IRMA ID 83393865xPUB224
Title Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer
Author Chin, Suyin P.
Marthick, James R.
West, Alison C.
Short, Annabel K.
Chuckowree, Jyoti
Polanowski, Andrea M.
Thomson, Russell J.
Holloway, Adele F.
Dickinson, Joanne L.
Journal Name Prostate
Publication Date 2015
Volume Number 75
Issue Number 7
ISSN 0270-4137   (check CDU catalogue open catalogue search in new window)
Scopus ID 2-s2.0-84926442113
Start Page 723
End Page 734
Total Pages 12
Place of Publication United States
Publisher John Wiley & Sons, Inc.
Field of Research MEDICAL AND HEALTH SCIENCES
HERDC Category C1 - Journal Article (DIISR)
Abstract BACKGROUND
Integrin alpha2 beta1 (α2β1) plays an integral role in tumour cell invasion, metastasis and angiogenesis, and altered expression of the receptor has been linked to tumour prognosis in several solid tumours. However, the relationship is complex, with both increased and decreased expression associated with different stages of tumour metastases in several tumour types. The ITGA2 gene, which codes for the α2 subunit, was examined to investigate whether a large CpG island associated with its promoter region is involved in the differential expression of ITGA2 observed in prostate cancer.

METHODS
Bisulphite sequencing of the ITGA2 promoter was used to assess methylation in formalin-fixed paraffin-embedded (FFPE) prostate tumour specimens and prostate cancer cell lines, PC3, 22Rv1 and LNCaP. Changes in ITGA2 mRNA expression were measured using quantitative PCR. ITGA2 functionality was interrogated using cell migration scratch assays and siRNA knockdown experiments.

RESULTS
Bisulphite sequencing revealed strikingly decreased methylation at key CpG sites within the promoter of tumour samples, when compared with normal prostate tissue. Altered methylation of this CpG island is also associated with differences in expression in the non-invasive LNCaP, and the highly metastatic PC3 and 22Rv1 prostate cancer cell lines. Further bisulphite sequencing confirmed that selected CpGs were highly methylated in LNCaP cells, whilst only low levels of methylation were observed in PC3 and 22Rv1 cells, correlating with ITGA2 transcript levels. Examination of the increased expression of ITGA2 was shown to influence migratory potential via scratch assay in PC3, 22Rv1 and LNCaP cells, and was confirmed by siRNA knockdown experiments.

CONCLUSIONS
Taken together, our data supports the assertion that epigenetic modification of the ITGA2 promoter is a mechanism by which ITGA2 expression is regulated.
DOI http://dx.doi.org/10.1002/pros.22954   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)
 
Versions
Version Filter Type
Access Statistics: 73 Abstract Views  -  Detailed Statistics
Created: Tue, 26 Jul 2016, 12:40:31 CST